Expression of interleukin‐18 in human ovarian carcinoma and normal ovarian epithelium: Evidence for defective processing in tumor cells

Authors:

Abstract
Interleukin‐18 (IL‐18) is a proinflammatory monokine structurally related to IL‐1β that stimulates interferon‐γ (IFN‐γ) production. IL‐18 is synthesized as an inactive precursor, pro‐IL‐18, which is cleaved by IL‐1β‐converting enzyme (ICE)/caspase‐1 in a mature protein. In view of the proposed use of IL‐18 in cancer immuno/gene therapy, we have studied the expression of IL‐18 in tumor cells. IL‐18 mRNA was detected by reverse transcriptase polymerase chain reaction in all human ovarian carcinoma cell lines tested (9/9) and in one‐half of tumor cell populations obtained from ovarian carcinoma patients (4/8). ICE mRNA was expressed in a smaller fraction of samples (3/9 cell lines and 3/8 samples from patients). IL‐18 protein was also found in 7/13 ovarian carcinoma solid tumors by immunohistochemic analysis. In tumor cell lines we were able to detect abundant intracellular pro‐IL‐18 (24 kDa) by Western blotting, whereas the mature form of IL‐18 was undetectable, irrespective of the presence of ICE mRNA and protein. Only pro‐IL‐18 was also found in the ovarian carcinoma cell supernatants, which did not display any IL‐18 biologic activity in functional assays. Normal cultured ovarian epithelial cells revealed the presence of both IL‐18 and ICE mRNA in all samples (5/5) and IL‐18 protein was expressed by the thin epithelial cell layer surrounding normal ovary. More importantly, normal ovarian epithelial cells released low but detectable amounts of mature IL‐18 in the culture supernatant, which displayed IL‐18‐like biologic activity in functional assays. These data suggest that mature biologically active IL‐18 production is a feature of the normal ovarian surface epithelium lost during neoplastic transformation.

This publication has 40 references indexed in Scilit: